Equibles does not estimate personal net worth.
Get an email with a short summary when Standard Biotools Inc. publishes a filing, an earnings call transcript or a press release.
Get LAB alertsThe proxy statement of Standard Biotools Inc. reports total compensation of $1,105,664 for Vikram Jog in fiscal 2021, including a base salary of $384,300. Disclosed compensation is on record for 5 fiscal years. Vikram Jog has spoken on 12 earnings calls across 1 company, most recently for Standard Biotools Inc. on May 9, 2023. Standard Biotools Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Standard Biotools Inc. includes Dr. Josh Bilenker (CEO), Dr. Michael Egholm (CEO), Michael Egholm (CEO and Board Member) and 7 others.
“As Michael noted, we are pleased with our results for the first quarter, delivering year-over-year growth in topline core product and service revenues and margins and significant improvement in cash flow from operations.”
“As Michael noted, we are pleased with our results for the fourth quarter, which showed top line sequential improvement in our core revenue. Let me begin with a review of core revenue for the fourth quarter and full year 2022.”
“As Michael noted, we are pleased with our results for the third quarter, which showed top line sequential improvement across all the geographic markets we serve.”
“As noted in our earnings release today, we are simplifying our product offerings and discontinuing our Laser Capture Microdissection or LCM and flow conductor products and de-emphasizing our diagnostics or COVID-19 activity.”
“Before turning to our first quarter financial results, I would like to note that we have posted this presentation, including updated supplemental financial information, on our website.”
SEC 8-K
2023-05-15–present
Start not stated–2023-05-14
Medical Devices · Healthcare
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $384,300 | $1,105,664 |
| 2020 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $347,783 | $1,443,226 |
| 2019 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $362,274 | $1,391,445 |
| 2018 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $355,979 | $1,125,539 |
| 2017 | Standard Biotools Inc. (LAB) | Chief Financial Officer | $344,592 | $974,126 |
